Requiring health plan companies to cover health care services for the home treatment of bleeding episodes associated with certain chronic bleeding disorders (hemophilia or von Willebrand's disease) using plasma protein therapies and for the home treatment of primary immunodeficiency diseases and other conditions reliant on immune globulin treatment and appha-1 and anti-trypsin disorder, specifying certain requirements for health plan companies; defining certain terms; prescribing certain duties for home care providers treating bleeding disorders; providing for plasma protein therapies to be covered by medical assistance
(me)